Sectors

The UPMC-backed cancer biotherapeutics developer priced its shares in the middle of their range in its initial public offering.

NeoGenomics has agreed to buy portfolio company Inivata, a liquid biopsy platform developer, a year after it invested $25m.

Mogrify has collected $17m in a second series A tranche led by Parkwalk Advisors to bring the round’s total to $33m.

Framestore Ventures had backed the online comics platform developer's series B round, before the latter announced its closure last month.

Ahren Innovation Capital has helped bring Zoe’s overall financing to $53m by leading a series B round for the personalised nutrition service.

Harvard University’s endowment has participated in a funding round for the robo-advisory platform.

Athenex will pay $70m upfront and up to $115m in milestone payments to acquire Kuur Therapeutics, providing exits to Baylor College and IP Group.

NeoGenomics has exercised its option to buy Inivata, a precision cancer diagnostics company that was formed to exploit Cambridge and CRUK research seven years ago.

Ant Group has reportedly not supplied the $73.5m in funding it pledged for the mobile wallet developer Wave a year ago.

Solidia Technologies, Kelun Biotech and Doer Biologics all raised more than $70m while Sony added cash to a round valuing Discord at $7bn.

Oxford University Innovation has revealed it launched 37 new companies between April 2020 and March 2021, its best run yet.